Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-21 to 2024-01-16
Current total value of award: $13674.8
Description: 4563180766!NEXPLANON 68 MG IMPLANTS